-transparent.png){kind=logo}
Two nine-year-old boys with haemophilia A and circulating inhibitor against factor VIII were given large doses of commercial AHG concentrates to control bleeding. But the isoagglutinins in the AHG concentrates caused haemolysis in both patients. When AHF (Immuno) from AB donors - a cryoprecipate without isoagglutinins - was used no further inhibitor activity was detectable, previously observed anaphylactoid reactions no longer occurred and usual doses of AHG were now sufficient to control bleeding.
Related Publications
K Bartholomé, and
H Geiger, and
K Schimpf
December 1975,
Haematologica,
K Bartholomé, and
H Geiger, and
K Schimpf
December 1977,
Journal of neurology, neurosurgery, and psychiatry,
K Bartholomé, and
H Geiger, and
K Schimpf
July 1975,
Lancet (London, England),
K Bartholomé, and
H Geiger, and
K Schimpf
June 1974,
Deutsche medizinische Wochenschrift (1946),
K Bartholomé, and
H Geiger, and
K Schimpf
February 1979,
Deutsche medizinische Wochenschrift (1946),
K Bartholomé, and
H Geiger, and
K Schimpf
December 1975,
Lancet (London, England),
K Bartholomé, and
H Geiger, and
K Schimpf
December 1973,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
K Bartholomé, and
H Geiger, and
K Schimpf
March 1977,
Deutsche medizinische Wochenschrift (1946),
K Bartholomé, and
H Geiger, and
K Schimpf
January 1978,
Sangre,
K Bartholomé, and
H Geiger, and
K Schimpf
November 1980,
British medical journal,
